All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 2 minutes Smart ...

We independently select these products—if you buy from one of our links, we may earn a commission. All prices were accurate at the time of publishing. Having a backyard or patio space is always nice, ...

Using a power bank while it's charging is something everyone has done at an airport, cafe, or any location with limited power outlets. This can be a smart move when traveling, since it ensures your ...

As the global energy transition moves from capacity growth to quality growth, solar plants are being asked to deliver more than nameplate output. Developers, investors and grid operators now expect ...

Abstract: The discrete Fourier transform (DFT) is still a widely used tool for analyzing and measuring both stationary and transient signals in power system harmonics. However, the misapplications of ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

On the occasion of receiving the most influential test-of-time paper award for his POPL 2011 paper (which describes the technology behind the popular Flash Fill feature in Excel), Sumit shares stories ...

Abstract: This paper introduces an innovative approach to classify disturbances in power quality (PQ) by combining principal component analysis (PCA), recursive feature elimination (RFE) and logistic ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up ...